These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Androgen treatment and anti-androgens]. König MP Schweiz Med Wochenschr; 1969 May; 99(20):744-7. PubMed ID: 5785442 [No Abstract] [Full Text] [Related]
3. [Contribution to the long-term treatment of severe androgen deficiency with 1-alpha-methyl-5-alpha-androstan-17-beta-ol-3-one (mesterolone)]. Hornstein O Arzneimittelforschung; 1966 Apr; 16(4):466-8. PubMed ID: 6014251 [No Abstract] [Full Text] [Related]
4. Therapeutic uses of androgenic agents. Smith GB; Farber M Compr Ther; 1984 Apr; 10(4):11-6. PubMed ID: 6373113 [No Abstract] [Full Text] [Related]
5. [Andropause, male climacteric and crisis of the fifties: should androgens be administered?]. Martin-Du Pan R; Martin-du Pan S; Sindelar P Rev Med Suisse Romande; 1995 Mar; 115(3):257-62. PubMed ID: 7777768 [No Abstract] [Full Text] [Related]
6. [Treatment of male fertility disorders]. Rusz A Orv Hetil; 2005 Nov; 146(48):2459-63. PubMed ID: 16408386 [No Abstract] [Full Text] [Related]
7. [Andrology--medical aspects]. Hall K Lakartidningen; 1990 Dec; 87(49):4169-70. PubMed ID: 2263131 [No Abstract] [Full Text] [Related]
8. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review. Mäkinen JI; Huhtaniemi I Gerontology; 2011; 57(3):193-202. PubMed ID: 20689266 [TBL] [Abstract][Full Text] [Related]
9. [Choice of treatment of erectile dysfunction associated with hypogonadism]. Aliaev IuG; Vinarov AZ; Akhvlediani ND Urologiia; 2010; (4):37-8, 40-2. PubMed ID: 20967981 [TBL] [Abstract][Full Text] [Related]
11. Men's health. Summary and table. Palmer KJ; Wiseman L; Poole R Drugs R D; 1999 Dec; 2(6):401-11. PubMed ID: 10763452 [No Abstract] [Full Text] [Related]
12. A study of treatment choices in men with erectile dysfunction and reduced androgen levels. Wylie K; Davies-South D J Sex Marital Ther; 2004; 30(2):107-14. PubMed ID: 14742100 [TBL] [Abstract][Full Text] [Related]
13. [Mestoranum. What justification has this androgenic steroid?]. Frey H Tidsskr Nor Laegeforen; 1973 May; 93(15):1163-4. PubMed ID: 4751605 [No Abstract] [Full Text] [Related]
14. Androgen function after age 50 and treatment of hypogonadism. Korenman SG Curr Ther Endocrinol Metab; 1997; 6():621-4. PubMed ID: 9174818 [No Abstract] [Full Text] [Related]
15. [Basic principles of modern androgenic therapy]. Ludvik W Urologe; 1970 Jan; 9(1):41-3. PubMed ID: 5418835 [No Abstract] [Full Text] [Related]
16. Clomiphene citrate and enclomiphene for the treatment of hypogonadal androgen deficiency. Kaminetsky J; Hemani ML Expert Opin Investig Drugs; 2009 Dec; 18(12):1947-55. PubMed ID: 19938905 [TBL] [Abstract][Full Text] [Related]
17. Androgen treatment without inhibiting effect on hypophysis and male gonads. Biochemical and morphological studies after treatment with Mesterolone. Petry R; Rausch-Stroomann JG; Hienz HA; Senge T; Mauss J Acta Endocrinol (Copenh); 1968 Nov; 59(3):497-507. PubMed ID: 4880965 [No Abstract] [Full Text] [Related]
18. The aging male: androgens, erectile dysfunction, and depression. Seidman SN J Clin Psychiatry; 2003; 64 Suppl 10():31-7. PubMed ID: 12971814 [TBL] [Abstract][Full Text] [Related]